Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Phase 2
Recruiting
- Conditions
- Relapsed or Refractory Peripheral T-cell Lymphoma
- Interventions
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2025-03-11
- Target Recruit Count
- 33
- Registration Number
- NCT05833724
- Locations
- π¨π³
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
π¨π³National Taiwan University Hospital, Taipei, Taiwan
π¨π³Chang Gung Memorial Hospital, Kaohsiung, Kaohsiung, Taiwan
Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)
Phase 1
Terminated
- Conditions
- Hepatocellular Carcinoma (HCC)
- Interventions
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2025-03-11
- Target Recruit Count
- 7
- Registration Number
- NCT05770882
- Locations
- π¨π³
Chang Gung Memorial Hospital, Kaohsiung, Kaohsiung, Taiwan
π¨π³China Medical University Hospital, Taichung, Taiwan
π¨π³National Cheng Kung University Hospital, Tainan, Taiwan
Β© Copyright 2025. All Rights Reserved by MedPath